Jul 16, 2025 04:01PM
Jul 16, 2025 04:01PM
Jul 15, 2025 09:10AM
Jul 15, 2025 09:10AM
Jul 7, 2025 05:24PM
Mar 27, 2025 04:07PM
Feb 14, 2025 04:38PM Form S-1 60 DEGREES PHARMACEUTICA
May 8, 2024 07:59AM
Apr 3, 2024 07:58AM
Apr 3, 2024 07:58AM
Feb 8, 2024 07:59AM
Feb 8, 2024 07:59AM
Jan 31, 2024 11:15AM
Jan 30, 2024 09:01AM 60 Degrees Pharmaceuticals (SXTP) Prices 5.26M Unit Offering at $0.375/unit
Jan 30, 2024 09:00AM
Jan 22, 2024 03:58PM
Jan 22, 2024 07:59AM
Jan 22, 2024 07:59AM
Jan 16, 2024 07:59AM
Jan 16, 2024 07:59AM
Dec 26, 2023 07:59AM 60 Degrees Pharmaceuticals (SXTP) Announces IRB Approval of Phase IIA Study of Tafenoquine for Babesiosis
Dec 26, 2023 07:59AM
Nov 15, 2023 07:29AM
Nov 15, 2023 07:29AM
Oct 19, 2023 08:31AM
Oct 12, 2023 04:16PM
Oct 12, 2023 04:16PM
Aug 22, 2023 07:32AM 60 Degrees Pharmaceuticals (SXTP) Granted Additional U.S. Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria
Aug 22, 2023 07:31AM
Aug 15, 2023 07:31AM
Aug 15, 2023 07:31AM
Jul 31, 2023 07:59AM
Jul 31, 2023 07:59AM
Jul 14, 2023 01:30PM
Jul 14, 2023 12:39PM 60 Degrees Pharmaceuticals Announces Closing of Initial Public Offering
Jul 12, 2023 01:45PM
Jul 12, 2023 01:45PM
Jul 12, 2023 12:29PM

66,422 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All